These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11371125)

  • 1. Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention.
    Rodríguez-Burford C; Barnes MN; Berry W; Partridge EE; Grizzle WE
    Gynecol Oncol; 2001 Jun; 81(3):373-9. PubMed ID: 11371125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA125 expression in spontaneous ovarian adenocarcinomas from laying hens.
    Jackson E; Anderson K; Ashwell C; Petitte J; Mozdziak PE
    Gynecol Oncol; 2007 Jan; 104(1):192-8. PubMed ID: 16942793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis.
    Barnes MN; Berry WD; Straughn JM; Kirby TO; Leath CA; Huh WK; Grizzle WE; Partridge EE
    Gynecol Oncol; 2002 Oct; 87(1):57-63. PubMed ID: 12468343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma.
    Giles JR; Shivaprasad HL; Johnson PA
    Gynecol Oncol; 2004 Dec; 95(3):530-3. PubMed ID: 15581958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhesus macaque model for ovarian cancer chemoprevention.
    Brewer M; Baze W; Hill L; Utzinger U; Wharton JT; Follen M; Khan-Dawood F; Satterfield W
    Comp Med; 2001 Oct; 51(5):424-9. PubMed ID: 11924802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical assessment of proliferation markers and altered gene expression in archival specimens of ovarian epithelial tumors.
    Khalifa MA; Lacher DA; Lage JM; Mannel RS; Walker JL; Angros LH; Min KW
    Cancer Detect Prev; 1997; 21(6):532-9. PubMed ID: 9398993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of two antigens OC41 D and OC41 E associated with ovarian carcinoma].
    Cui H
    Zhonghua Fu Chan Ke Za Zhi; 1993 May; 28(5):284-6, 314-5. PubMed ID: 8243148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
    Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
    Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological and phenotypic characterization of a new established ovarian carcinoma cell line (OvBH-1).
    Bar JK; Harlozińska A
    Anticancer Res; 2000; 20(5A):2975-80. PubMed ID: 11062710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
    Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
    J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: antigens for multi-targeted antibody-guided therapy.
    Chauhan SC; Vinayek N; Maher DM; Bell MC; Dunham KA; Koch MD; Lio Y; Jaggi M
    J Histochem Cytochem; 2007 Aug; 55(8):867-75. PubMed ID: 17478446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas.
    Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD
    Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct--a comparative study with assessment of ovarian carcinomas for expression of glial fibrillary acidic protein.
    Idowu MO; Rosenblum MK; Wei XJ; Edgar MA; Soslow RA
    Am J Surg Pathol; 2008 May; 32(5):710-8. PubMed ID: 18360284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical study of new monoclonal antibodies--E29, 115D8 --to an epithelial membrane antigen (EMA) in ovarian tumors].
    Fujimoto I; Fukuda K; Hang SP; Hasumi K; Masubuchi K; Osamura Y; Watanabe K
    Gan No Rinsho; 1987 Nov; 33(14):1798-804. PubMed ID: 2826841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance.
    Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins AC; Li Y
    Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical demonstration of CA 125, CA 19-9 and CEA in normal and pathologically changed adnexa].
    Neunteufel W; Breitenecker G
    Geburtshilfe Frauenheilkd; 1988 May; 48(5):334-7. PubMed ID: 3165079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer.
    Aggarwal S; He T; Fitzhugh W; Rosenthal K; Feild B; Heidbrink J; Mesmer D; Ruben SM; Moore PA
    Gynecol Oncol; 2009 Dec; 115(3):430-7. PubMed ID: 19800108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jejunal adenocarcinoma presenting as a primary ovarian carcinoma.
    Kilic G; Abadi M
    Gynecol Oncol; 2000 Aug; 78(2):255-8. PubMed ID: 10926813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.